Hypertension and depression: Coexisting barriers to medication adherence

Journal of Clinical Hypertension

Volumn 12, Issue 7, 2010, Pages 481-486

  Krousel Wood, Marie A ^a,b,c   Frohlich, Edward D ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b TULANE UNIVERSITY   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT;

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COMORBIDITY; DEPRESSION; DOCTOR PATIENT RELATION; EDITORIAL; ENDOGENOUS DEPRESSION; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; SELF CONCEPT; SELF REPORT;

ANTIHYPERTENSIVE AGENTS; DEPRESSION; HUMANS; HYPERTENSION; MEDICATION ADHERENCE;

EID: 77955254671     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00302.x     Document Type: Editorial

References (36)

1. Krousel-Wood M, Thomas S, Muntner P. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004, 19:357-362.
2. Krousel-Wood MA, Muntner P, Islam T. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am 2009, 93:753-769.
3. Hyre A, Krousel-Wood MA, Muntner P. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) 2007, 9:179-186.
4. Krousel-Wood M, Muntner P, Jannu A. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci 2005, 330:128-133.
5. Bokhour BG, Belowitz DR, Long JA. How do providers assess antihypertensive medication adherence in medical encounters? J Gen Intern Med 2006, 21:577-583.
6. Krousel-Wood MA, Islam T, Webber LS. New medication adherence scale versus pharmacy fill rates in hypertensive seniors. Am J Manag Care 2009, 15:59-66.
7. Sackett DL, Sackett DL, Haynes RB. Introduction. Compliance With Therapeutic Regimens 1976, 1-6. In, eds, Baltimore, MD, Johns Hopkins University Press
8. Elliott WJ. Compliance-and improving it-in hypertension. Manag Care 2003, 12:56-61.
9. Stephenson J. Noncompliance may cause half of antihypertensive drug "failures" JAMA 1999, 282:313-314.
10. Susic D, Krousel-Wood M, Zhou X. Partial adherence to antihypertensive therapy fails to achieve full cardiovascular benefits in hypertensive rats. Am J Med Sci 2008, 335:420-425.
11. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991, 38:1978-1988.
12. Harmon G, Lefante J, Krousel-Wood MA. The role of providers in improving patient adherence to antihypertensive medications. Curr Opin Cardiol 2006, 21:310-315.
13. Heisler M, Hogan MM, Hofer TP. When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation 2008, 117:2884-2892.
14. Chobanian AV, Bakris GL, Black HR. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
15. Ong KL, Cheung BM, Man YB. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007, 49:69-75.
16. Bogner HR, Cary MS, Bruce ML. The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study. Am J Geriatr Psychiatry 2005, 13:861-868.
17. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000, 160:3278-3285.
18. Scalco AZ, Scalco MZ, Azul JB. Hypertension and depression. Clinics 2005, 60:241-250.
19. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
20. Kim MT. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med 2003, 26:24-31.
21. Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav 2009, 36:127-137.
22. Wang PS, Bohn RL, Knight E. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002, 17:504-511.
23. Wing RR, Phelan S, Tate D. The role of adherence in mediating the relationship between depression and health outcomes. J Psychosom Res 2002, 53:877-881.
24. Young AS, Klap R, Sherbourne CD. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58:55-61.
25. Krousel-Wood M, Hyre A, Muntner P. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol 2005, 20:296-300.
26. Hawkshead J, Krousel-Wood MA. Techniques of measuring medication adherence in hypertensive patients in outpatient settings: advantages and limitations. Dis Manage Health Outcomes 2007, 15:109-118.
27. Morisky DE, Ang A, Krousel-Wood MA. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008, 10:348-354.
28. Lichtman JH, Bigger JT, Blumenthal JA. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008, 118:1768-1775.
29. Bogner HR, de Vries HF. Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med 2008, 6:295-301.
30. Henkel V, Seemuller F, Obermeier M. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord 2009, 115:439-449.
31. Amsterdam JD, Garcia-Espana F, Fawcett J. Blood pressure changes during short-term fluoxetine treatment. J Clin Psychopharmacol 1999, 19:9-14.
32. Scalco MZ, de Almeida OP, Hachul DT. Comparison of risk of orthostatic hypotension in elderly depressed hypertensive women treated with nortriptyline and thiazides versus elderly depressed normotensive women treated with nortriptyline. Am J Cardiol 2000, 85:1156-1158.
33. Chang-Quan H, Bi-Rong D, Zhen-Chan L. Collaborative care interventions for depression in the elderly: a systematic review of randomized controlled trials. J Investig Med 2009, 57:446-455.
34. Rose LE, Kim MT, Dennison CR. The contexts of adherence for African Americans with high blood pressure. J Adv Nurs 2000, 32:587-594.
35. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009, 119:3028-3035.
36. Krouselwood MA, Islam T, Muntner P. Depression and older adults: impact of depressive symptoms on medication adherence. Perspective from COSMO American Heart Association 50th Cardiovascular Disease Epidemiology and Prevention Conference. March 4, 2010. San Francisco, CA: Abstract P237 in session "Aging."